Successful Treatment of an Elderly Patient With Combined Small Cell Lung Cancer Receiving Anlotinib: A Case Report

Combined small-cell lung cancer (C-SCLC) is a relatively rare subtype of SCLC and is defined by the combination of SCLC and any elements of non-small-cell lung carcinoma. Anlotinib is a novel oral multitarget tyrosine kinase inhibitor that led to significant improvements in progression-free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Yuying, Liu, Pingli, Luo, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632010/
https://www.ncbi.nlm.nih.gov/pubmed/34858856
http://dx.doi.org/10.3389/fonc.2021.775201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632010/
https://www.ncbi.nlm.nih.gov/pubmed/34858856
http://dx.doi.org/10.3389/fonc.2021.775201

Ejemplares similares